NewsRx

Search our medical news database

Diabetes

Studies from Denmark, Canada and the United States advance knowledge in diabetes research

Published in Obesity and Diabetes Week, August 14th, 2006

Diabetes research advances have been reported from Denmark, Canada and the United States.

Study 1: Galactin-3 plays a key role in immune-mediated beta-cell destruction in type 1 diabetes.

"Proapoptotic cytokines are toxic to the pancreatic beta-cells and have been associated with the pathogenesis of type I diabetes (T1D). Proteome analysis of IL-1beta exposed isolated rat islets identified galectin-3 (gal-3) as the most upregulated protein. Here analysis of human and rat islets and insulinoma cells confirmed IL-1 beta regulated gal-3 expression of several gal-3 isoforms and a complex in vivo expression profile during diabetes development in rats,"...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook